Cefazolin versus cloxacillin in methicillin-susceptible Staphylococcus aureus endocarditis: Too good to be true? Authors' reply

被引：0
|
作者：
Herrera-Hidalgo, Laura [1 ,2 ,3 ]
de Alarcon, Aristides [2 ,3 ]
机构：
[1] Univ Hosp Virgen del Rocio, Dept Pharm, Seville, Spain
[2] Univ Seville, Univ Hosp Virgen del Rocio, Spanish Natl Res Council, Inst Biomed Seville,Dept Infect Dis Microbiol & Pa, Seville, Spain
[3] Inst Salud Carlos III, CIBER Enfermedades Infecciosas CIBERINFEC, Madrid, Spain
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2024年 / 142卷
关键词：
D O I：
10.1016/j.ijid.2024.02.022
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis
    Singh, Kavindra V.
    Tran, Truc T.
    Nannini, Esteban C.
    Tam, Vincent H.
    Arias, Cesar A.
    Murray, Barbara E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (07)
  • [42] Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis
    Castaneda, Ximena
    Garcia-De-la-Maria, Cristina
    Gasch, Oriol
    Pericas, Juan M.
    Soy, Dolors
    Canas-Pacheco, Maria-Alejandra
    Falces, Carlos
    Garcia-Gonzalez, Javier
    Hernandez-Meneses, Marta
    Vidal, Barbara
    Almela, Manel
    Quintana, Eduard
    Tolosana, Jose M.
    Fuster, David
    Llopis, Jaume
    Dahl, Anders
    Moreno, Asuncion
    Marco, Francesc
    Miro, Jose M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (06) : 1539 - 1546
  • [43] Disseminated methicillin-susceptible Staphylococcus aureus infection
    Perkins, David R.
    Hall, James A.
    Lopez, Lisa M.
    Cahuayme-Zuniga, Lizbeth Janice
    JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 67 (01) : 83 - 86
  • [44] THE BORDERLINE METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS-AUREUS
    VARALDO, PE
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (01) : 1 - 4
  • [45] Potent Activity of Ertapenem Plus Cefazolin Within Staphylococcal Biofilms: A Contributing Factor in the Treatment of Methicillin-Susceptible Staphylococcus aureus Endocarditis
    Gilbertie, Jessica
    Ulloa, Erlinda R.
    Daiker, Jennifer C.
    Nguyen, Khanh
    Smelter, Dan
    Rose, Warren
    Geriak, Matthew
    Schnabel, Lauren, V
    Nizet, Victor
    Sakoulas, George
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (05):
  • [46] A Comparison of Cefazolin Versus Ceftriaxone for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia in a Tertiary Care VA Medical Center
    Carr, Dustin R.
    Stiefel, Usha
    Bonomo, Robert A.
    Burant, Christopher J.
    Sims, Sharanie V.
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (05):
  • [47] Prevalence and Characterization of the Cefazolin Inoculum Effect in North American Methicillin-Susceptible Staphylococcus aureus Isolates
    Dingle, Tanis C.
    Gamage, Dulini
    Gomez-Villegas, Sara
    Hanson, Blake M.
    Reyes, Jinnethe
    Abbott, April
    Burnham, Carey-Ann D.
    Bard, Jennifer Dien
    Fritz, Stephanie
    Miller, William R.
    Westblade, Lars F.
    Zimmer, Barbara
    Arias, Cesar A.
    Butler-Wu, Susan
    JOURNAL OF CLINICAL MICROBIOLOGY, 2022, 60 (07)
  • [48] Tolerability of Cefazolin in Nafcillin-Intolerant Patients for the Treatment of Methicillin-Susceptible Staphylococcus aureus Infections
    Gandhi, Ankit M.
    Shah, Megan D.
    Donohue, Lindsay E.
    Cox, Heather L.
    Eby, Joshua C.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : 1650 - 1655
  • [49] Impact of Hypoalbuminemia on Clinical Outcomes in Patients Receiving Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
    Whitenack, Kaylee M.
    Ilges, Dan
    Epps, Kevin L.
    Mcgary, Alyssa
    Robinson, John C.
    ANNALS OF PHARMACOTHERAPY, 2025,
  • [50] Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone
    S. A. Winans
    A. M. Luce
    R. Hasbun
    Infection, 2013, 41 : 769 - 774
12345